2018
DOI: 10.5530/jppcm.2018.2.19
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Outcomes of Drug-related Problems in Saudi Arabia: Patients’ and Healthcare Providers’ Perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 11 publications
0
12
0
Order By: Relevance
“…Drug-related problems had a noteworthy apprehension clinically and economically in Saudi Arabia and the rest of the world. [39][40][41][42][43] Drugrelated problems contained of various issues, comprising medication errors, adverse drug reactions, drugs without indication, indications without medications, non-compliance and poisoning. [44] The pharmaceutical care concept was executed before 20 years to prevent drugrelated problems worldwide.…”
Section: Discussionmentioning
confidence: 99%
“…Drug-related problems had a noteworthy apprehension clinically and economically in Saudi Arabia and the rest of the world. [39][40][41][42][43] Drugrelated problems contained of various issues, comprising medication errors, adverse drug reactions, drugs without indication, indications without medications, non-compliance and poisoning. [44] The pharmaceutical care concept was executed before 20 years to prevent drugrelated problems worldwide.…”
Section: Discussionmentioning
confidence: 99%
“…As a result, drug-related problems, comprising medication errors, had likely issues with a high economic burden in Saudi Arabia based on patients and health care providers, comprising dentists. 1,2 Also, various studies deliberated patient safety the dental field. [3][4][5][6] Other publications addressed the medication safety elements to stop dental errors, including medications.…”
Section: Introductionmentioning
confidence: 99%
“…Drug-related problem (DRP) is defined as, "an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes" according to the pharmaceutical care network of Europe (PCNE) (6). Strong evidence had shown that negative health outcomes are associated with DRPs, such as increased healthcare costs, prolonged hospital stays, reduced quality of life, and increased mortality (7)(8)(9). Patients with cancer are at high risk of DRPs due to multi-morbidity associated polypharmacy.…”
Section: Introductionmentioning
confidence: 99%